Q/C Technologies, Inc. Equity Securities, FV-NI, Realized Gain (Loss)
Q/C Technologies, Inc. (QCLS) reported Equity Securities, FV-NI, Realized Gain (Loss) of -$14.40 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2021-05-18
- Q/C Technologies, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-03-31 was -$14.40K.
- Q/C Technologies, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2020-12-31 was $22.64K.
- Q/C Technologies, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2020-09-30 was $31.46K.
- Q/C Technologies, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2020 was $54.10K.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$14.40K 10-Q · filed 2021-05-18 | $8.23K derived: sum of 2 quarters · filed 2021-05-18 | $39.70K derived: sum of 3 quarters · filed 2021-05-18 | |
| 2020-12-31 | $22.64K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $54.10K derived: sum of 2 quarters · filed 2021-03-01 | $54.10K 10-K · filed 2021-03-01 | |
| 2020-09-30 | $31.46K 10-Q · filed 2020-11-16 | $31.46K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |